Filing Details

Accession Number:
0001209191-16-142527
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-09-22 17:48:08
Reporting Period:
2016-09-20
Filing Date:
2016-09-22
Accepted Time:
2016-09-22 17:48:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1077183 Neogenomics Inc NEO Services-Testing Laboratories (8734) 742897368
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591950 Maher Albitar 12701 Commonwealth Drive Suite 9
Fort Myers FL 33913
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2016-09-20 105,300 $8.20 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 63,492 Indirect Shares owned by Albitar Oncology Defined Benefit Plan
Common Stock 105,300 Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $7.15 2017-04-20 2021-04-20 200,000 200,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2021-04-20 200,000 200,000 Direct
Footnotes
  1. On April 20, 2016, Dr. Albitar was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.